Compare iShares MSCI Canada (TSX) (EWC) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Canada (TSX) vs 22nd Century Group Inc — how do they compare? iShares MSCI Canada (TSX) trades at $61.82, while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: iShares MSCI Canada (TSX) is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| EWC | XXII | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $61.51 | $801.00 |
52-Week Low | $47.00 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWC trades at $61.72, up 0.35% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF remains focused on Canadian equities, showing double-digit returns in 2026 but trailing the S&P 500. Recent news highlights trade tensions with the U.S., including potential 50% tariffs on Canadian goods, though key sectors like energy are exempt.
Outlook is mixed: bullish technicals and strong 2026 performance support upside, but trade war risks and overbought conditions pose near-term headwinds. Investors should weigh Canada's economic resilience against tariff uncertainties for balanced exposure.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Canada (TSX)
EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.
Read more on EWC →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
